The American Society of Nuclear Cardiology and the American College of Cardiology submitted joint comments asking for tariffs on radiopharmaceuticals to be delayed until domestic sources can be established.
The development of a domestic supply of molybdenum-99 has been a priority for years, but the U.S. still does not have a supply, according to a May 12 news release from the ASNC.
The Department of Commerce recently launched an investigation to determine the impact of importing pharmaceuticals and pharmaceutical ingredients on national security.
At the conclusion of the investigation, the department will make its recommendations to President Donald Trump, the release said.
Read the full comments from the organizations here.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.